Human Centriole and Centrosome Antibody IgG ELISA Kit |
MBS039049-10x96StripWells |
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Human IgG antibody Laboratories manufactures the fct005 luciferase lenti reagents distributed by Genprice. The Fct005 Luciferase Lenti reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact luciferase assay. Other Fct005 products are available in stock. Specificity: Fct005 Category: Luciferase Group: Lenti
Human True Insulin ELISA Kit |
MyBiosource |
10x96-Strip-Wells |
EUR 6725 |
Human True Insulin ELISA Kit |
MyBiosource |
48-Strip-Wells |
EUR 550 |
Human True Insulin ELISA Kit |
MyBiosource |
5x96-Strip-Wells |
EUR 3420 |
Human True Insulin ELISA Kit |
MyBiosource |
96-Strip-Wells |
EUR 765 |
Human True Insulin GENLISA ELISA |
Krishgen |
1 x 96 wells |
EUR 286 |
Human True insulin ELISA kit |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Human True insulin ELISA kit |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human True insulin ELISA kit |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human True insulin ELISA kit |
BlueGene |
48 wells plate |
EUR 280 |
Lenti information
ARE Luciferase Reporter Lentivirus |
79869 |
BPS Bioscience |
500 µl x 2 |
EUR 875 |
Description: The Nrf2 antioxidant response pathway plays an important role in the cellular antioxidant defense. Nrf2, a basic leucine zipper transcription factor, induces the expression of antioxidant and phase II enzymes by binding to the ARE (antioxidant response element) region of the gene promoter. Under basal conditions, Nrf2 is retained in the cytosol by binding to the cytoskeletal protein Keap1. Upon exposure to oxidative stress or other ARE activators, Nrf2 is released from Keap1 and translocates to the nucleus, where it can bind to the ARE, leading to the expression of antioxidant and phase II enzymes that protect the cell from oxidative damage. The ARE Luciferase Reporter Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by ARE located upstream of the minimal TATA promoter. After transduction, activation of the Nrf2 antioxidant response pathway in the target cells can be monitored by measuring the luciferase activity. |
TEAD Luciferase Reporter Lentivirus |
79833 |
BPS Bioscience |
500 µl x 2 |
EUR 875 |
Description: The Hippo pathway regulates cell proliferation and cell death. It is activated by high cell density and cell stress to stop cell proliferation and induce apoptosis. The mammalian Hippo pathway comprises MST kinases and LATS kinases. When the Hippo pathway is activated, MST kinases phosphorylate LATS kinases, which phosphorylate transcriptional co-activators YAP and TAZ. Unphosphorylated YAP and TAZ remain in nucleus and interact with TEAD/TEF transcriptional factors to turn on cell cycle-promoting gene transcription. However, when phosphorylated, YAP and TAZ are recruited from the nucleus to the cytosol, so that the YAP and TAZ-dependent gene transcription is turned off. Dysfunction of the Hippo pathway is frequently detected in human cancer and its down-regulation correlates with the aggressive properties of cancer cells and poor prognosis. The TEAD Luciferase Reporter Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by the TEAD response elements located upstream of the minimal TATA promoter. After transduction, activation of the Hippo pathway in the target cells can be monitored by measuring the luciferase activity._x000D_ |
β-Lactamase (Luciferase) lentiviral particles |
LVP335-luc |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 206.5 |
Description: pre-made lentiviral particles expressing β-Lactamase gene. A firefly luciferase marker was expressed under RSV promoter. Particles is provided in DMEM medium with 10% FBS and 60ug/ml of polybrene. |
STAT3 Luciferase Reporter Lentivirus |
79744 |
BPS Bioscience |
500 µl x 2 |
EUR 860 |
Description: The STAT3 Luciferase Reporter Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene under the control of STAT3-responsive element located upstream of the minimal TATA promoter. After transduction, activation of the STAT3 signaling pathway in the target cells can be monitored by measuring the luciferase activity._x000D_ |
STAT5 Luciferase Reporter Lentivirus |
79745 |
BPS Bioscience |
500 µl x 2 |
EUR 835 |
Description: The STAT5 Luciferase Reporter Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene under the control of STAT5-responsive element located upstream of the minimal TATA promoter. After transduction, activation of the STAT5 signaling pathway in the target cells can be monitored by measuring the luciferase activity. |
NF-κB Luciferase Reporter Lentivirus |
79564 |
BPS Bioscience |
500 µl x 2 |
EUR 875 |
Description: The NF-κB Luciferase Reporter Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by four copies of the NF-κB response element located upstream of the minimal TATA promoter. After transduction, activation of the NF-κB signaling pathway in the target cells can be monitored by measuring the luciferase activity. |
Renilla Luciferase (Rluc) Lentivirus (G418) |
79565-G |
BPS Bioscience |
500 µl x 2 |
EUR 820 |
Description: The Renilla Luciferase Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles constitutively express Renilla luciferase under a CMV promoter._x000D_ _x000D_ |
CRE/CREB Luciferase Reporter Lentivirus |
79580 |
BPS Bioscience |
500 µl x 2 |
EUR 835 |
Description: The main role of the cAMP response element, or CRE, is mediating the effects of Protein Kinase A (PKA) by way of transcription. Upon phosphorylation, CREB forms a functionally active dimer that binds the CRE element within the promoters of target genes and activates transcription. CRE is at the focus of many extracellular and intracellular signaling pathways, including cAMP, calcium, GPCR (G-protein coupled receptors) and neurotrophins. The cAMP/PKA signaling pathway is critical to numerous life processes in living organisms.The CRE/CREB Luciferase Reporter Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by multimerized cAMP response element (CRE) located upstream of the minimal TATA promoter. After transduction, activation of the cAMP/PKA signaling pathway in the target cells can be monitored by measuring the luciferase activity. |
Secreted Gaussia Luciferase Lentivirus CMV Promoter |
79892-C |
BPS Bioscience |
500 µl x 2 |
EUR 795 |
Description: The Secreted Gaussia Luciferase Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles constitutively express secreted Gaussia luciferase under a CMV promoter or EF1-a promoter._x000D_ _x000D_ |
NFAT Luciferase-RFP Reporter Lentivirus |
78617-H |
BPS Bioscience |
500 µl x 2 |
EUR 835 |
Description: The NFAT Luciferase-RFP Reporter Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase and RFP (Red Fluorescent Protein) cassette driven by the NFAT response element located upstream of the minimal TATA promoter and a hygromycin or puromycin selection gene to generate stable clones. After transduction, activation of the NFAT signaling pathway in the target cells can be monitored by measuring the luciferase activity or RFP expression. RFP fluoresces red-orange when excited; it has an excitation wavelength of 553 nm, and an emission wavelength of 574 nm. |
NFAT Luciferase-RFP Reporter Lentivirus |
78617-P |
BPS Bioscience |
500 µl x 2 |
EUR 835 |
Description: The NFAT Luciferase-RFP Reporter Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase and RFP (Red Fluorescent Protein) cassette driven by the NFAT response element located upstream of the minimal TATA promoter and a hygromycin or puromycin selection gene to generate stable clones. After transduction, activation of the NFAT signaling pathway in the target cells can be monitored by measuring the luciferase activity or RFP expression. RFP fluoresces red-orange when excited; it has an excitation wavelength of 553 nm, and an emission wavelength of 574 nm. |
Firefly Luciferase-eGFP Lentivirus (G418) |
79980-G |
BPS Bioscience |
500 µl x 2 |
EUR 875 |
Description: The Firefly Luciferase-eGFP Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types mammalian cells, including primary and non-dividing cells. These viruses contain a firefly luciferase and eGFP cassette (Luc-P2A-eGFP) driven by a CMV promoter. Both the luciferase and eGFP are coexpressed under the CMV promoter in the transduced cells, allowing greater flexibility for detection of transduced cells. |
Luciferase-2A-CRE (Bsd), lentiviral particles |
LVP304 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 315 |
Description: Pre-made lentiviral particles bicistronically express individual firefly luciferase and nuclear permeable CRE recombinase under the same suCMV promoter. A Blasticidin marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS. |
Luciferase-2A-CRE (Neo), lentiviral particles |
LVP410 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 315 |
Description: Pre-made lentiviral particles bicistronically express individual firefly luciferase and nuclear permeable CRE recombinase under the same suCMV promoter. A Neomycin marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS. |
Secreted Gaussia Luciferase Lentivirus EF1a Promoter |
79892-E |
BPS Bioscience |
500 µl x 2 |
EUR 795 |
Description: The Secreted Gaussia Luciferase Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles constitutively express secreted Gaussia luciferase under a CMV promoter or EF1-a promoter._x000D_ _x000D_ |
Luciferase-mCherry Lentiviral Vector (CMV) |
LV010138 |
ABM |
1.0 μg |
EUR 230 |
Luciferase-2A-CRE (Puro), lentiviral particles |
LVP409 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 315 |
Description: Pre-made lentiviral particles bicistronically express individual firefly luciferase and nuclear permeable CRE recombinase under the same suCMV promoter. A Puromycin marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS. |
Firefly Luciferase-eGFP Lentivirus (Puromycin) |
79980-P |
BPS Bioscience |
500 µl x 2 |
EUR 875 |
Description: The Firefly Luciferase-eGFP Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types mammalian cells, including primary and non-dividing cells. These viruses contain a firefly luciferase and eGFP cassette (Luc-P2A-eGFP) driven by a CMV promoter. Both the luciferase and eGFP are coexpressed under the CMV promoter in the transduced cells, allowing greater flexibility for detection of transduced cells. |
IL-2 Promoter Luciferase Reporter Lentivirus |
79825 |
BPS Bioscience |
500 µl x 2 |
EUR 795 |
Description: The IL-2 Promoter Luciferase Reporter Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by the human IL-2 promoter. After transduction, activation of the IL-2 signaling pathway in the target cells can be monitored by measuring the luciferase activity._x000D_ |
IL-8 Promoter Luciferase Reporter Lentivirus |
79827 |
BPS Bioscience |
500 µl x 2 |
EUR 795 |
Description: The IL-8 Promoter Luciferase Reporter Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by the human IL-8 promoter. After transduction, activation of the IL-8 signaling pathway in the target cells can be monitored by measuring the luciferase activity._x000D_ |
Non-secreted Gaussia Luciferase Lentivirus (CMV Promoter) |
79893-C |
BPS Bioscience |
500 µl x 2 |
EUR 795 |
Description: The Non-secreted Gaussia Luciferase Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles constitutively express Gaussia luciferase lacking the N-terminal signal peptide under a CMV promoter._x000D_ |
Luciferase-2A-CRE, (GFP-Bsd) lentiviral particles |
LVP411 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 315 |
Description: Pre-made lentiviral particles bicistronically express individual firefly luciferase and nuclear permeable CRE recombinase under the same suCMV promoter. A GFP-Blasticidin fusion dual marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS. |
Luciferase-2A-CRE, (RFP-Bsd) lentiviral particles |
LVP413 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 315 |
Description: Pre-made lentiviral particles bicistronically express individual firefly luciferase and nuclear permeable CRE recombinase under the same suCMV promoter. A RFP-Blasticidin fusion dual marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS. |
NFAT Luciferase Reporter Lentivirus-79579-G |
79579-G |
BPS Bioscience |
500 µl x 2 |
EUR 835 |
Description: The NFAT Luciferase Reporter Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by the NFAT response element located upstream of the minimal TATA promoter (Figure 1) and an antibiotic selection gene (hygromycin, puromycin, or G418) for the selection of stable clones. After transduction, activation of the NFAT signaling pathway in the target cells can be monitored by measuring the luciferase activity. |
NFAT Luciferase Reporter Lentivirus-79579-H |
79579-H |
BPS Bioscience |
500 µl x 2 |
EUR 860 |
Description: The NFAT Luciferase Reporter Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by the NFAT response element located upstream of the minimal TATA promoter and an antibiotic selection gene (hygromycin or puromycin) for the selection of stable clones. After transduction, activation of the NFAT signaling pathway in the target cells can be monitored by measuring the luciferase activity. |
NFAT Luciferase Reporter Lentivirus-79579-P |
79579-P |
BPS Bioscience |
500 µl x 2 |
EUR 860 |
Description: The NFAT Luciferase Reporter Lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to transduce almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene driven by the NFAT response element located upstream of the minimal TATA promoter and an antibiotic selection gene (hygromycin or puromycin) for the selection of stable clones. After transduction, activation of the NFAT signaling pathway in the target cells can be monitored by measuring the luciferase activity. |
Bald Lentiviral Pseudovirion (Luciferase Reporter) |
79943 |
BPS Bioscience |
500 µl x 2 |
EUR 875 |
Description: The bald lentiviral pseudovirion was produced without envelope glycoproteins such as VSV-G or SARS-CoV-2 spike. It contains the firefly luciferase gene driven by a CMV promoter as the reporter. The bald lentiviral pseudovirion can serve as a negative control when studying virus entry initiated by specific interactions between virus particles and receptors._x000D_ |
Luciferase (Cypridina), (Bsd), Concentrated Lentivirus |
LVP378-PBS |
GenTarget |
5x107 IFU/ml x 200ul |
EUR 455 |
Description: Pre-made lentiviral particles expressing Cypridina luciferase with Blastidicin marker. Particles were concentrated and provided in PBS solution |